Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Do you organise talks?

Register to tell us about them. The Lecture List is a great place to be listed, but it's also an easy place to upload your information to. It's very simple and costs nothing. Find out more

Help!

Find out what you can do to keep The Lecture List online

A silent killer?

Michael Faraday Prize Lecture


This is the 'golden age' of cancer research; 50 years of painstaking scientific detective work has finally paid off. Scientists studying the life and death of bacteria, yeast, mouse and human cells have gained a deep understanding of the molecules that go wrong in cancer. This knowledge is already leading to drugs that hit the target with less collateral damage. In the years to come, increasing numbers of people will live with their cancer rather than die of it.

But some cancers present more of a challenge than others. Cancer of the ovary is a silent killer, rarely showing its presence until it has spread far and wide. How will our understanding of the molecular biology of this disease translate into new ways for its early detection and treatment?

In communicating the challenges and hopes for the future, Professor Fran Balkwill of Queen Mary's School of Medicine and Dentistry will demonstrate how cancer scientists can help patients and their families, as well as inspire young people to take up careers in this exciting area of science.


Speaker(s):

Professor Fran Balkwill | talks

 

Date and Time:

25 January 2006 at 5:30 pm

Duration:

1 hour

 

Venue:

The Royal Society
6-9 Carlton House Terrace
London
SW1Y 5AG
+44 20 74 51 2500
http://www.royalsociety.org

More at The Royal Society...

 

Tickets:

FREE

Available from:

Admission is free and on a first come, first served basis - no ticket or advance booking required.

Register to tell a friend about this lecture.

Comments

If you would like to comment about this lecture, please register here.



 

Any ad revenue is entirely reinvested into the Lecture List's operating fund